Study period | |||||||||
---|---|---|---|---|---|---|---|---|---|
Pre-procedure | Post-procedure | ||||||||
Enrolment | Within 2/52 | Days post-procedure | Months | ||||||
Timepoint | T-1 | T0 | D1 | Discharge | D7-10 | D28 | 2–6 | 9 | 12 |
Enrolment: | |||||||||
Clinical assessment | X | X | X | X | X | X | X | X | |
Bedside ultrasounda | X | X | X | X | X | X | |||
Informed consent | X | ||||||||
Baseline data collection | X | ||||||||
Blood testsb | X | ||||||||
CXRc | X | X | X | X | X | X | |||
Randomisation (IVRS) | X | ||||||||
Interventions: | |||||||||
Drainage procedure (VATS or IPC) | X | ||||||||
Assessments: | |||||||||
Questionnaires (VAS QoL, dyspnoea, pain; EQ5D5L) | X | X | X | ||||||
Logbook commencement | X | ||||||||
Logbook collection | X | ||||||||
Procedure-related data collection | X | ||||||||
ActiGraph to participant—lead site only | X | X | X | ||||||
Assessment for pleurodesisd | X | X | X | X | X | ||||
Assessment for re-intervention | X | X | X | X | X | X | |||
Adverse event review | X | X | X | X | X | X |